Details of Disease

General Information of Disease (ID: DISX6A86)

• Disease Name: Vaccination
• Disease Class: N.A.: Vaccination
• Disease Hierarchy:
  DIS01GPL: Grass pollen hypersensitivity
  DISX6A86: Vaccination
• ICD Code: ICD-11: ICD-11: N.A.

Drug-Interaction Atlas (DIA) of This Disease

This Disease is Treated as An Indication in 1 Approved Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
Vaccinia immune globulin	DMA630M	Approved	NA	[1]

This Disease is Treated as An Indication in 2 Clinical Trial Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
CAF-01	DMQ7WJI	Phase 1	NA	[2]
Matrix M	DMNME3Y	Phase 1	NA	[3]

This Disease is Treated as An Indication in 1 Investigative Drug(s)

Drug Name	Drug ID	Highest Status	Drug Type	REF
BioVant	DMVOJ0X	Investigative	Vaccine	[4]

Molecular Interaction Atlas (MIA) of This Disease

References

• [1] Countermeasures and vaccination against terrorism using smallpox: pre-event and post-event smallpox vaccination and its contraindications. Environ Health Prev Med. 2011 Sep; 16(5): 281-289.
• [2] A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human. Vaccine. 2014 Dec 12;32(52):7098-107.
• [3] Clinical pipeline report, company report or official report of Novavax.
• [4] Calcium Phosphate Nanoparticle Adjuvant. Clin Diagn Lab Immunol. 2000 November; 7(6): 899-903.